Wednesday, November 20, 2024
HomeIndustriesHealthcare

Healthcare

Moleculin Announces Completion of First Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...

Cizzle Biotechnology Announces Strategic Agreement with the Behnke Group to Enhance U.S. Market Presence

Cizzle Biotechnology Holdings PLC, the UK based diagnostics developer, is pleased to announce that it has entered into an agreement with the Behnke Group,...

Nonagen Bioscience Announces CE Mark for Oncuria Bladder Cancer Diagnostic

Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria immunoassay for bladder cancer. Oncuria is the first-of-its-kind multiplex urine test for the...

Cordis Announces Successful First-in-Human Use of the Radianz Radial Peripheral System

Cordis, a global leader in cardiovascular technologies, announced the first-in-human use of the Radianz Radial Peripheral System by Jihad Mustapha, MD, FACC, FSCAI at...

DiA Imaging Analysis Partners with Intelerad Medical Systems to Empower Echocardiography Labs with AI

Intelerad Medical Systems, a global leader in medical image management solutions, and DiA Imaging Analysis, a leading global provider of AI-based ultrasound software solutions,...
0FansLike
0FollowersFollow
spot_img

Hot Topics